Skip to main content
. 2021 Jun 15;36(5):2954–2961. doi: 10.1007/s00464-021-08589-6

Table 2.

Summary of the outcomes of PuraStat treatment

Outcome of PuraStat treatment
Primary use of PuraStat N = 79
Procedure success, n (%) 74 (94%, 95% CI 88–99)
Application of additional techniques after Purastat* 32/74 (43%, 95% CI 32–54)
Secondary use of PuraStat N = 32
 Procedure success, n (%) 24 (75%, 95% CI 59–91)
Outcome
 Overall procedure success, n (%) 98/111 (88%, 95% CI 82–94)
 Overall therapeutic success after 3 days, n (%) 96/111 (87%, 95% CI 80–93)
 Overall therapeutic success after 7 days, n (%) 90/111 (81%, 95% CI 72–88)
 Rebleeding, n (%) 18/111 (16%, 95% CI 10–24)
  Within 7 days after the procedure 13
  After 7 days 5
 With bridging to surgery 5/111

95%CI 95% confidence interval

*Additional techniques applied to stabilise haemostasis according to guidelines and/or if deemed necessary by the physician